Società Italiana Metabolismo Diabete Obesità

Recensioni e articoli originali



16/06/2017

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes


16/06/2017

FIRST ITALIAN EXPERIENCE WITH CONTINUOUS INTRAPERITONEAL INSULIN INFUSION (CIPII) VIA DIAPORT SYSTEM


15/06/2017

Canaglifozin riduce gli eventi cardiovascolari e renali nelle persone con diabete, ma aumenta il rischio di amputazioni

leggi la News


01/08/2016

Vascular calcification in diabetic foot and its association with calcium homeostasis.

leggi la News


14/07/2016

Brown RE & Kuk JL Consequences of obesity and weight loss: a devil’s advocate position

leggi la News


14/07/2016

Consequences of obesity and weight loss: a devil’s advocate position

leggi la News


26/09/2014

World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients

leggi la News


01/01/2013

The Economics of New Drugs: Can We Afford to Make Progress in a Common Disease?

leggi la News


11/03/2016

Propaganda or the cost of innovation? Challenging the high price of new drugs

leggi la News


24/05/2012

Medico-economic Evaluation of Health Products in the Context of the Social Security Financing Act for 2012

leggi la News


16/05/2014

Leveraging Public Private Partnerships to Innovate Under Challenging Budget Times

leggi la News


24/11/2013

Financial Aspects and the Future of the Pharmaceutical Industry in the United States of America

leggi la News


24/05/2015

Corporate social responsibility in global health: an exploratory study of multinational pharmaceutical firms

leggi la News


17/10/2014

The Role of OSAS on Metabolic Disorders

leggi la News


24/05/2016

SONNO E RISCHIO CARDIOMETABOLICO TRIBUTO ALLA

leggi la News